Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.
Over the last 12 months, insiders at Tango Therapeutics, Inc. have bought $11.17M and sold $7.16M worth of Tango Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Tango Therapeutics, Inc. have bought $6.09M and sold $3.58M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Boxer Capital, LLC () — $67.01M.
The last purchase of 500,000 shares for transaction amount of $3.42M was made by Boxer Capital, LLC () on 2023‑10‑16.
2024-06-07 | Sale | MVA Investors, LLC | See remarks | 77,000 0.0719% | $6.88 | $529,760 | +34.20% | |
2024-06-06 | Sale | MVA Investors, LLC | See remarks | 63,000 0.0593% | $7.24 | $456,120 | +26.32% | |
2024-06-05 | Sale | Calhoun Lesley Ann | director | 5,000 0.0046% | $7.21 | $36,039 | +20.51% | |
2024-05-03 | Sale | MVA Investors, LLC | See remarks | 60,000 0.0562% | $7.61 | $456,600 | -0.79% | |
2024-05-02 | Sale | MVA Investors, LLC | See remarks | 75,000 0.07% | $7.56 | $567,000 | -0.26% | |
2024-05-01 | Sale | MVA Investors, LLC | See remarks | 75,000 0.0717% | $7.43 | $557,250 | +4.26% | |
2024-02-20 | Sale | Third Rock Ventures IV, L.P. | 10 percent owner | 162,500 0.1619% | $12.00 | $1.95M | -34.44% | |
2024-02-07 | Sale | Weber Barbara | Chief Executive Officer | 4,457 0.0046% | $12.62 | $56,246 | -38.99% | |
2024-02-07 | Sale | Beckman Daniella | Chief Financial Officer | 1,817 0.0019% | $12.62 | $22,930 | -38.99% | |
2024-02-07 | Sale | Crystal Adam | See Remarks | 4,083 0.0042% | $12.62 | $51,527 | -38.99% | |
2024-02-07 | Sale | Barry Douglas | General Counsel | 1,354 0.0014% | $12.62 | $17,087 | -38.99% | |
2024-02-06 | Sale | Weber Barbara | Chief Executive Officer | 4,681 0.0048% | $12.56 | $58,806 | -38.96% | |
2024-02-06 | Sale | Beckman Daniella | Chief Financial Officer | 1,908 0.002% | $12.56 | $23,969 | -38.96% | |
2024-02-06 | Sale | Crystal Adam | See Remarks | 4,288 0.0044% | $12.56 | $53,868 | -38.96% | |
2024-02-06 | Sale | Barry Douglas | General Counsel | 1,422 0.0015% | $12.56 | $17,864 | -38.96% | |
2023-11-01 | Sale | Crystal Adam | See Remarks | 7,507 0.0075% | $8.39 | $62,994 | +2.31% | |
2023-10-16 | Boxer Capital, LLC | 500,000 0.5093% | $6.84 | $3.42M | +27.91% | |||
2023-10-13 | Boxer Capital, LLC | 750,000 0.6778% | $7.07 | $5.3M | +8.32% | |||
2023-10-09 | Sale | Boxer Capital, LLC | 225,000 0.2231% | $9.96 | $2.24M | -15.60% | ||
2023-08-11 | Boxer Capital, LLC | 475,000 0.3675% | $5.15 | $2.45M | +9.59% |
Third Rock Ventures IV, L.P. | 10 percent owner | 19201475 18.8268% | $8.87 | 0 | 1 | |
Boxer Capital, LLC | 8198642 8.0387% | $8.87 | 3 | 1 | ||
Weber Barbara | Chief Executive Officer | 1535167 1.5052% | $8.87 | 0 | 2 | |
MVA Investors, LLC | See remarks | 343524 0.453% | $8.87 | 0 | 5 | |
Beckman Daniella | Chief Financial Officer | 132397 0.1298% | $8.87 | 0 | 2 | |
Crystal Adam | See Remarks | 119478 0.1171% | $8.87 | 0 | 3 | |
Barry Douglas | General Counsel | 43981 0.0431% | $8.87 | 0 | 2 | |
Calhoun Lesley Ann | director | 6250 0.0058% | $8.87 | 0 | 1 | |
Davis Aaron I. | director | 7123642 6.9846% | $8.87 | 3 | 0 | +36.98% |
LEWIS JOSEPH | director | 7053642 6.916% | $8.87 | 3 | 0 | +39.17% |
BCTG Holdings, LLC | 10 percent owner | 4488450 4.4009% | $8.87 | 1 | 1 | +7.42% |
Trv Gp Iv Llc | $152.46M | 17.97 | 19.2M | -0.84% | -$1.29M | 73.88 | |
Ecor1 Capital Llc | $105.85M | 12.48 | 13.33M | 0% | +$0 | 2.69 | |
Fidelity Investments | $75.36M | 8.88 | 9.49M | -3.02% | -$2.35M | 0.01 | |
Boxer Capital, LLC | $65.1M | 7.67 | 8.2M | 0% | +$0 | 3.26 | |
Nextech Invest | $43.94M | 5.18 | 5.53M | 0% | +$0 | 7.16 | |
Southpoint Capital Advisors Lp | $41.9M | 4.94 | 5.28M | 0% | +$0 | 0.83 | |
T Rowe Price Investment Management Inc | $34.31M | 4.05 | 4.32M | +1,407.37% | +$32.04M | 0.02 | |
BlackRock | $30.66M | 3.61 | 3.86M | -2.23% | -$698,037.18 | <0.01 | |
The Vanguard Group | $24.46M | 2.88 | 3.08M | +3.41% | +$807,283.66 | <0.0001 | |
Bain Capital Life Sciences Investors Llc | $22.97M | 2.71 | 2.89M | 0% | +$0 | 2.31 | |
State Street | $22.76M | 2.68 | 2.87M | +192.78% | +$14.98M | <0.01 | |
Adage Capital Partners Gp L L C | $18.22M | 2.15 | 2.29M | -32.52% | -$8.78M | 0.03 | |
Artal Group S A | $17.43M | 2.05 | 2.19M | New | +$17.43M | 0.09 | |
Deerfield Management | $12.23M | 1.44 | 1.54M | 0% | +$0 | 0.24 | |
Soleus Capital Management, L.P. | $10.72M | 1.26 | 1.35M | +59.38% | +$3.99M | 0.1 | |
Casdin Capital | $9.44M | 1.11 | 1.19M | 0% | +$0 | 0.7 | |
Geode Capital Management | $9M | 1.06 | 1.13M | +3.32% | +$289,315.82 | <0.01 | |
Baker Bros Advisors LP | $5.96M | 0.7 | 750,000 | 0% | +$0 | 0.08 | |
Arrowmark Colorado Holdings Llc | $5.62M | 0.66 | 708,385 | 0% | +$0 | 0.01 | |
Bessemer Group Inc | $5.63M | 0.66 | 708,384 | 0% | +$0 | 0.01 | |
Samsara Biocapital Llc | $5M | 0.59 | 630,000 | 0% | +$0 | 0.78 | |
Goldman Sachs | $4.87M | 0.57 | 613,702 | +36.62% | +$1.31M | <0.01 | |
Ensign Peak Advisors Inc | $4.02M | 0.47 | 506,382 | +2.25% | +$88,681.86 | 0.01 | |
Citadel Advisors LLC | $3.7M | 0.44 | 466,118 | +130.96% | +$2.1M | <0.01 | |
Northern Trust | $3.18M | 0.38 | 401,129 | -2.73% | -$89,523.52 | <0.01 | |
Charles Schwab | $3.01M | 0.36 | 379,477 | +2.82% | +$82,663.33 | <0.01 | |
Mass General Brigham Inc | $2.81M | 0.33 | 354,192 | New | +$2.81M | 4.92 | |
Nuveen | $2.77M | 0.33 | 348,336 | -16.97% | -$565,407.43 | <0.01 | |
Two Sigma | $2.44M | 0.29 | 307,235 | +29.97% | +$562,493.44 | <0.01 | |
Dimensional Fund Advisors | $1.87M | 0.22 | 235,656 | +293.32% | +$1.4M | <0.01 | |
Rafferty Asset Management Llc | $1.75M | 0.21 | 220,019 | New | +$1.75M | 0.01 | |
Connor Clark & Lunn Investment Management Ltd | $1.56M | 0.18 | 196,384 | +8.74% | +$125,340.84 | <0.01 | |
Citigroup | $1.52M | 0.18 | 191,433 | +2,245.13% | +$1.46M | <0.01 | |
Barclays | $1.46M | 0.17 | 183,486 | -9.12% | -$146,311.73 | <0.01 | |
Morgan Stanley | $1.43M | 0.17 | 179,519 | +25.18% | +$286,729.31 | <0.0001 | |
Readystate Asset Management Lp | $1.34M | 0.16 | 168,400 | New | +$1.34M | 0.08 | |
UBS | $1.26M | 0.15 | 158,226 | New | +$1.26M | <0.0001 | |
Affinity Asset Advisors | $1.19M | 0.14 | 150,274 | -49.95% | -$1.19M | 0.21 | |
Wellington Management Company | $1.12M | 0.13 | 140,995 | -17.17% | -$232,109.96 | <0.0001 | |
BNY Mellon | $1M | 0.12 | 126,250 | -10.44% | -$116,860.92 | <0.0001 | |
JPMorgan Chase | $974,214.00 | 0.12 | 122,697 | +146.37% | +$578,778.25 | <0.0001 | |
Marshall Wace | $867,596.00 | 0.1 | 109,269 | New | +$867,596.00 | <0.01 | |
Bank of America | $857,862.00 | 0.1 | 108,043 | +80.69% | +$383,081.44 | <0.0001 | |
Fisher Asset Management Llc | $799,486.00 | 0.09 | 100,691 | 0% | +$0 | <0.0001 | |
Voloridge Investment Management, LLC | $684,118.00 | 0.08 | 86,161 | -24.66% | -$223,876.13 | <0.01 | |
State of Wisconsin Investment Board | $644,188.00 | 0.08 | 81,132 | +101.03% | +$323,737.58 | <0.01 | |
Swiss National Bank | $636,788.00 | 0.08 | 80,200 | 0% | +$0 | <0.0001 | |
American Century Investments | $623,107.00 | 0.07 | 78,477 | +11.46% | +$64,059.88 | <0.0001 | |
RhumbLine Advisers | $567,199.00 | 0.07 | 71,437 | +1.49% | +$8,313.02 | <0.01 | |
Federated Hermes | $532,893.00 | 0.06 | 67,115 | +42,922.44% | +$531,654.36 | <0.01 |